Key terms

About ZLAB

Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ZLAB news

Apr 11 7:35am ET Executive officers of Zai Lab ‘do not anticipate selling any shares’ in 2024 Apr 09 6:20am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inozyme Pharma (INZY), Zai Lab (ZLAB) and Idexx Laboratories (IDXX) Apr 01 7:39am ET Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints Mar 27 9:36am ET Zai Lab says partner Novocure’s Phase 3 trial met primary endpoint Mar 01 12:59am ET Buy Rating Affirmed for Zai Lab Amidst Strong Growth and Positive Future Outlook Feb 29 6:38am ET Buy Rating on Zai Lab with a Target Price of $66 Amid Vyvgart’s Growth Potential and Strategic Positioning Feb 29 6:24am ET Zai Lab price target lowered to $66 from $123 at Citi Feb 29 1:03am ET Zai Lab Ltd’s New Share Price & Shareholder Rights Risk – A Cause for Worry? Feb 28 6:59am ET Buy Rating Affirmed for Zai Lab on Strong Product Performance and Upbeat Revenue Projections Feb 28 5:36am ET Zai Lab’s Growth and Pipeline Prompts Buy Rating: Analyst David Li’s Financial Outlook and Price Objective Feb 27 4:40pm ET Zai Lab reports FY23 EPS (35c), consensus ($3.15) Feb 21 9:26am ET Zai Lab price target lowered to $31 from $37 at BofA Feb 21 5:31am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Medtronic (MDT), Globus Medical (GMED) and Zai Lab (ZLAB) Feb 09 5:03am ET Zai Lab Secures Debt Facilities to Boost Capital Flexibility Feb 05 7:55am ET Zai Lab management to meet with Cantor Fitzgerald Feb 05 4:55am ET Zai Lab management to meet with Cantor Fitzgerald Jan 31 7:53am ET Zai Lab management to meet with Cantor Fitzgerald Jan 27 12:07pm ET Zai Lab price target lowered to $44 from $66 at JPMorgan Jan 24 1:44am ET Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), Arcus Biosciences (RCUS) and Zai Lab (ZLAB)

No recent news articles are available for ZLAB

No recent press releases are available for ZLAB

ZLAB Financials

1-year income & revenue

Key terms

ZLAB Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ZLAB Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms